Myeloproliferative diseases (CML excluded)

MYELOPROF_NONCML

No definition available.

Endpoint definition

↥
FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector
diagram bullet

Check conditions

not CML

428936

diagram downward connector

Check pre-conditions, main-only, mode, registry filters None

0 out of 7 registries used, show all original rules.

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

2043

diagram downward connector
MYELOPROF_NONCML

Control definitions

Control conditions not CML

Extra metadata

First used in FinnGen datafreeze DF2, additional

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 2043 1055 988
Unadjusted prevalence (%) 0.50 0.46 0.54
Mean age at first event (years) 61.73 60.67 62.86

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.08 4.08 [2.22, 7.50] 5.7e-6 447
15 years 0.02 2.59 [1.70, 3.95] 9.9e-6 220
5 years 0.00 3.40 [2.52, 4.59] 1.2e-15 114
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: MYELOPROF_NONCML – Myeloproliferative diseases (CML excluded)
GWS hits: 18

Survival analyses between endpoints

↥

Plot

before Myeloproliferative diseases (CML excluded)
after Myeloproliferative diseases (CML excluded)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Myeloproliferative diseases (CML excluded)

↥

Endpoint not on priority list, no data to show.